Cocrystal Pharma Announces 1-for-30 Reverse Stock Split
23 janv. 2018 09h15 HE
|
Cocrystal Pharma, Inc.
– Reverse stock split positions Company to uplist to the NASDAQ Capital Market in Q1 2018 – – Company expects to commence Phase 2a study in Q1 2018 for lead program, CC-31244, for the treatment of...